This inventor holds 7 USPTO granted patents and 8 published patent applications and 3 EPO patents. Top assignees: University of Valencia, Fibrostatin Sociedad Limitada, Fibrostatin, S.l.. Active years: 2008-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Moncada, ES (2011 - 2013)
- Valencia, ES (2008 - 2020)
Company Filing History:
3 out of 52 
2 out of 2 
1 out of 1 Years Active: 2008-2020
Title: Innovations and Contributions of Inventor Fernando Revert
Introduction
Fernando Revert is a notable inventor based in Valencia, Spain. He has made significant contributions to the field of medical science, particularly in the diagnosis and treatment of various diseases. With a total of 7 patents to his name, Revert's work has the potential to impact many lives.
Latest Patents
Among his latest patents is a method for treating and diagnosing diseases using inhibitors of Goodpasture antigen binding protein. This invention provides methods for the diagnosis and/or treatment of chronic kidney disease, immune complex-mediated glomerulonephritis, rheumatoid arthritis, and pulmonary fibrosis. Additionally, he has developed GPBP inhibition using Q-peptidomimetics, which discloses compounds that inhibit GPBP activity. These compounds are useful as therapeutics in antibody-mediated disorders, drug-resistant cancer, inflammation, protein misfolding, ER stress-mediated disorders, and aberrant apoptosis.
Career Highlights
Fernando Revert has worked with esteemed institutions such as the University of Valencia and Fibrostatin Sociedad Limitada. His career reflects a commitment to advancing medical research and developing innovative solutions for complex health issues.
Collaborations
Throughout his career, Revert has collaborated with notable individuals, including Juan Saus and Francisco Revert-Ros. These partnerships have contributed to the success of his research and inventions.
Conclusion
Fernando Revert's contributions to medical science through his patents and collaborations highlight his dedication to innovation. His work continues to pave the way for advancements in the treatment and diagnosis of critical health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile